Spravato Depression Treatment | Wilshire Institute for Interventional Psychiatry

Wilshire Institute of Interventional Psychiatry provides Spravato treatment for depression, a clinically proven solution for treatment-resistant depression (TRD). Spravato is an FDA-approved nasal spray administered in our clinical setting with private rooms for your comfort and relaxation. Most insurance plans cover the treatment costs, and Wilshire Institute ensures personalized care, offering a fresh and practical approach to mental health with minimal out-of-pocket expenses.

spravato covered by insurance Spravato Depression Treatment spravato for depression spravato nasal spray spravato nasal spray for depression spravato treatment for depression spravato treatment resistant depression